Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin for PTSD-related nightmares
RBR-688jqzPhase 3Recruiting
- Sponsor
- Universidade Federal de Santa Maria
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Doxazosin with Placebo (2 arms). Primary endpoint: Nightmare severity/frequency. Started Dec 2018; status: recruiting.
02
Drugs
doxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on RBR-688jqz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-688jqz.